Handa Pharmaceuticals, LLC (“Handa”) is a specialty pharmaceutical company established in the San Francisco Bay area in November 2005. Handa’s executive leadership has a proven track record of developing controlled-release prescription pharmaceutical products that are difficult to formulate.

Handa’s business model includes managing all aspects of the product development process through the submission of its Abbreviated New Drug Applications (ANDA) and 505(b)(2) New Drug Applications (NDA) to the United States Food and Drug Administration (FDA).